Skip to content
October 31, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
Global Landmarks to Glow in Teal, Green, and Pink for National Metastatic Breast Cancer Awareness Day global-landmarks-to-glow-in-teal-green-and-pink-for-national-metastatic-breast-cancer-awareness-day
  • Patient Advocacy and Support

Global Landmarks to Glow in Teal, Green, and Pink for National Metastatic Breast Cancer Awareness Day

Ali Ikhwan October 19, 2026
NEW YORK, NY — As the world enters the second week of October, a month traditionally synonymous...
Read More Read more about Global Landmarks to Glow in Teal, Green, and Pink for National Metastatic Breast Cancer Awareness Day
Navigating the "New Normal": Breast Cancer Canada Announces Comprehensive Survivorship Webinar Series for October 2026 navigating-the-new-normal-breast-cancer-canada-announces-comprehensive-survivorship-webinar-series-for-october-2026-3
  • Patient Advocacy and Support

Navigating the "New Normal": Breast Cancer Canada Announces Comprehensive Survivorship Webinar Series for October 2026

Iffa Jayyana October 19, 2026
TORONTO, ON — As medical advancements continue to improve the survival rates for breast cancer, the healthcare...
Read More Read more about Navigating the "New Normal": Breast Cancer Canada Announces Comprehensive Survivorship Webinar Series for October 2026
Groundbreaking Oklahoma Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth groundbreaking-oklahoma-research-uncovers-how-aggressive-breast-cancer-hijacks-immune-system-to-fuel-growth-1
  • Medical Research and Clinical Trials

Groundbreaking Oklahoma Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Layla Zulfa October 19, 2026
NORMAN, OK – In a significant stride toward understanding and potentially combating one of the most aggressive...
Read More Read more about Groundbreaking Oklahoma Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth
MacroGenics Initiates Landmark Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors macrogenics-initiates-landmark-phase-i-trial-for-novel-antibody-drug-conjugate-mgc030-in-advanced-solid-tumors
  • Medical Research and Clinical Trials

MacroGenics Initiates Landmark Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Suro Senen October 19, 2026
A pioneering study marks a significant step forward in the fight against difficult-to-treat cancers, offering new hope...
Read More Read more about MacroGenics Initiates Landmark Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors
Navigating the Complex Interplay: GLP-1 Medications and Breast Cancer Risk, Recurrence, and Treatment navigating-the-complex-interplay-glp-1-medications-and-breast-cancer-risk-recurrence-and-treatment
  • Patient Advocacy and Support

Navigating the Complex Interplay: GLP-1 Medications and Breast Cancer Risk, Recurrence, and Treatment

Ammar Sabilarrohman October 19, 2026
By Douglas Feil, NBCF Chief Program Officer The landscape of healthcare is in constant flux, with new...
Read More Read more about Navigating the Complex Interplay: GLP-1 Medications and Breast Cancer Risk, Recurrence, and Treatment
Global Illumination: The 2026 #LightUpMBC Campaign and the Urgent Push for Metastatic Breast Cancer Research global-illumination-the-2026-lightupmbc-campaign-and-the-urgent-push-for-metastatic-breast-cancer-research
  • Patient Advocacy and Support

Global Illumination: The 2026 #LightUpMBC Campaign and the Urgent Push for Metastatic Breast Cancer Research

Ammar Sabilarrohman October 19, 2026
NEW YORK, NY — As the world enters the second week of October, a month traditionally synonymous...
Read More Read more about Global Illumination: The 2026 #LightUpMBC Campaign and the Urgent Push for Metastatic Breast Cancer Research
A New Frontier in Oncology: Karen and Rob Hale Commit Historic $50 Million to Revolutionize Breast Cancer Research a-new-frontier-in-oncology-karen-and-rob-hale-commit-historic-50-million-to-revolutionize-breast-cancer-research
  • Patient Advocacy and Support

A New Frontier in Oncology: Karen and Rob Hale Commit Historic $50 Million to Revolutionize Breast Cancer Research

Reynand Wu October 19, 2026
NEW YORK, NY — In a move that signals a paradigm shift in philanthropic support for medical...
Read More Read more about A New Frontier in Oncology: Karen and Rob Hale Commit Historic $50 Million to Revolutionize Breast Cancer Research
Navigating the “New Normal”: Comprehensive Survivorship Strategies for Breast Cancer Patients navigating-the-new-normal-comprehensive-survivorship-strategies-for-breast-cancer-patients
  • Patient Advocacy and Support

Navigating the “New Normal”: Comprehensive Survivorship Strategies for Breast Cancer Patients

Pevita Pearce October 19, 2026
By [Journalist Name] The completion of active breast cancer treatment—surgery, chemotherapy, and radiation—is often celebrated as the...
Read More Read more about Navigating the “New Normal”: Comprehensive Survivorship Strategies for Breast Cancer Patients
Bridging the Data Gap: WHO Launches the SCORE Technical Package to Revolutionize Global Health Infrastructure bridging-the-data-gap-who-launches-the-score-technical-package-to-revolutionize-global-health-infrastructure
  • Breast Cancer Prevention and Lifestyle

Bridging the Data Gap: WHO Launches the SCORE Technical Package to Revolutionize Global Health Infrastructure

Evan Lee Salim October 19, 2026
In an era defined by the rapid spread of global health crises and the increasing complexity of...
Read More Read more about Bridging the Data Gap: WHO Launches the SCORE Technical Package to Revolutionize Global Health Infrastructure
Bridging the Gap: Can Iambic Therapeutics Succeed Where Other AI Drug Developers Have Stumbled? bridging-the-gap-can-iambic-therapeutics-succeed-where-other-ai-drug-developers-have-stumbled-3
  • Treatment Innovations

Bridging the Gap: Can Iambic Therapeutics Succeed Where Other AI Drug Developers Have Stumbled?

Lina Hope October 19, 2026
The intersection of artificial intelligence and pharmaceutical development has long been framed as the next great frontier...
Read More Read more about Bridging the Gap: Can Iambic Therapeutics Succeed Where Other AI Drug Developers Have Stumbled?

Posts pagination

Previous 1 … 55 56 57 58 59 60 61 … 841 Next

Recent Posts

  • AI Breakthrough at UCLA Health Offers Hope for Earlier Detection of Elusive Interval Breast Cancers
  • Geron Halts Late-Stage Myelofibrosis Trial of Rytelo After Efficacy Miss, Shifts Focus to Combination Therapy
  • A Public Servant’s Private Battle: Shona’s Journey from Diagnosis to Advocacy
  • Strengthening the Global Shield: UK and WHO Forge Path Toward Future Pandemic Resilience
  • Genmab’s Strategic Surge: A New Era of Growth Beyond the Darzalex Era

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

ai-breakthrough-at-ucla-health-offers-hope-for-earlier-detection-of-elusive-interval-breast-cancers
  • Medical Research and Clinical Trials

AI Breakthrough at UCLA Health Offers Hope for Earlier Detection of Elusive Interval Breast Cancers

Nana October 31, 2026
geron-halts-late-stage-myelofibrosis-trial-of-rytelo-after-efficacy-miss-shifts-focus-to-combination-therapy
  • Medical Research and Clinical Trials

Geron Halts Late-Stage Myelofibrosis Trial of Rytelo After Efficacy Miss, Shifts Focus to Combination Therapy

Ammar Sabilarrohman October 31, 2026
a-public-servants-private-battle-shonas-journey-from-diagnosis-to-advocacy
  • Patient Advocacy and Support

A Public Servant’s Private Battle: Shona’s Journey from Diagnosis to Advocacy

Laily UPN October 31, 2026
strengthening-the-global-shield-uk-and-who-forge-path-toward-future-pandemic-resilience
  • Breast Cancer Prevention and Lifestyle

Strengthening the Global Shield: UK and WHO Forge Path Toward Future Pandemic Resilience

Asep Darmawan October 31, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.